309 Oman H, Blomquist L, Henriksson AE, Johansson SG. Comparison of polysucrose 15000, 51Cr-labelled ethylenediaminetetraacetic acid, and 14C-mannitol as markers of intestinal permeability in man. Scand J Gastroenterol. 1995;30(12): 1172-1177. Aabakken L. Cr-ethylenediaminetetraacetic acid absorption test. Methodologic aspects. Scand J Gastroenterol. 1989;24(3): 351-358. Maxton DG, Bjarnason I, Reynolds AP, Catt SD, Peters TJ, Menzies IS. Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability. Clin Sci (Lond). 1986;71(1): 71-80. Binnerts W, Van ‘T Klooster AT, Frens AM. Soluble Chromium indicator measured by atomic absorption in digestion experiments. Veterinary Record. 1968;82: 470. Goullé J, Mahieu L, Castermant J, Neveu N, Bonneau L, Lainé G, et al. Metal and metalloid multielementary ICP-MS validation in whole blood, plasma, urine and hair. Forensic Sci Int. 2005;153(1): 39-44. Harmsen HJM, Raangs GC, He T, Degener JE, Welling GW. Extensive Set of 16S rRNA-Based Probes for Detection of Bacteria in Human Feces. Appl Environ Microbiol. 2002;68(6): 2982-2990. Suau A, Rochet V, Sghir A, Gramet G, Brewaeys S, Sutren M, et al. Fusobacterium prausnitzii and Related Species Represent a Dominant Group Within the Human Fecal Flora. Syst Appld Microbiol. 2001;24(1): 139-145. Amann RI, Binder BJ, Olson RJ, Chisholm SW, Devereux R, Stahl DA. Combination of 16S rRNA-Targeted Oligonucleotide Probes with Flow Cytometry for Analyzing Mixed Microbial Populations. Appl Environ Microbiol. 1990;56(6): 1919-1925. Poulsen LK, Lan F, Kristensen CS, Hobolth P, Molin S, Krogfelt KA. Spatial distribution of Escherichia coli in the mouse large intestine inferred from rRNA in situ hybridization. Infect Immun. 1994;62(11): 5191-5194. [Anonymous]. http://www.inchem.org/documents/ehc/ehc/ehc61.htm. Wang L, Llorente C, Hartmann P,YangAM, Chen P, Schnabl B. Methods todetermine intestinal permeability and bacterial translocation during liver disease. J Immunol Methods. 2015;421: 44-53. Scaioli E, Cardamone C, Scagliarini M, Zagari RM, Bazzoli F, Belluzzi A. Can fecal calprotectin better stratify Crohn’s disease activity index? Ann Gastroenterol. 2015;28(2): 247-252. Benitez JM, Meuwis MA, Reenaers C, Van Kemseke C, Meunier P, Louis E. Role of endoscopy, crosssectional imaging and biomarkers in Crohn’s disease monitoring. Gut. 2013;62(12): 1806-1816. Jones J, Loftus EV, Panaccione R, Chen LS, Peterson S, McConnell J, et al. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn’s disease. Clin Gastroenterol Hepatol. 2008;6(11): 1218-1224. Berstad A, Arslan G, Folvik G. Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid. Scand J Gastroenterol. 2000;35(1): 64-69. Suenaert P, Bulteel V, Vermeire S, Noman M, Van Assche G, Rutgeerts P. Hyperresponsiveness of the mucosal barrier in Crohn’s disease is not tumor necrosis factor-dependent. InflammBowel Dis. 2005;11(7): 667-673. Hiippala K, Jouhten H, Ronkainen A, Hartikainen A, Kainulainen V, Jalanka J, et al. The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation. Nutrients. 2018;10(8): pii: E988. Katz KD, Hollander D, Vadheim CM, McElree C, Delahunty T, Dadufalza VD, et al. Intestinal permeability in patients with Crohn’s disease and their healthy relatives. Gastroenterology. 1989;97(4): 927-931. Takeuchi K, Maiden L, Bjarnason I. Genetic aspects of intestinal permeability in inflammatory bowel disease. Novartis Found Symp. 2004;263: 151-158. 52Cr-EDTA intestinal permeability in Crohn’s disease 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57
RkJQdWJsaXNoZXIy MjY0ODMw